Intervacc’s developmental program for new vaccines against animal infectious diseases is summarised in the following table. Please, click on respective project name or indication to read more.

ProjectDisease areaSpeciesPreclinicalClinical RegulatoryMarket
INV274Strep. suis infectionPiglets
INV412Staph. aureus mastitisCow

The positive results of vaccination against strangles (Strangvac®), based on fusions of recombinant proteins, demonstrates that our technology can be applied also for development of other vaccines.